News

FDA Approves Fiasp for Children With Diabetes

The FDA has approved insulin aspart injection (Fiasp, Novo Nordisk), 100 U/mL, as a new mealtime option for children with diabetes—the first fast-acting mealtime insulin injection that does not have a pre-meal dosing recommendation. Diabetes is one of the most common chronic conditions of childhood, with nearly 18,000 new cases of type-1 diabetes diagnosed each […]

News

FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetes

(Reuters) – The U.S. Food and Drug Administration declined to approve a drug developed by Sanofi SA and Lexicon Pharmaceuticals Inc intended for use with insulin in patients with type 1 diabetes, the companies said on Friday. The decision comes about two months after an FDA advisory panel failed to reach a consensus over whether […]